• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail

Answers to Stakeholders' Questions

On April 28, 1999, the U.S. Food and Drug Administration (FDA) hosted a live satellite teleconference, "Talking with Stakeholders About FDA Modernization." In conjunction with this nationwide broadcast, FDA conducted regional meetings in eight cities around the country. Stakeholders from around the country were invited to fax or phone comments and/or questions to the FDA's featured guests, Dr. Jane E. Henney, Commissioner of Food and Drugs and Dr. Linda A. Suydam, Senior Associate Commissioner, along with a panel of senior Center representatives in the studio. Although a variety of stakeholder issues were addressed during the broadcast, unfortunately, there was not enough broadcast time to answer everyone. We did tell our viewers that we would not let your input evaporate into thin air. We are, therefore, posting the questions/comments that did not get answered during the broadcast with a response from FDA here.

The questions are organized by the following center-specific categories: biologics, drugs, medical devices, foods, science, inspections and enforcement, and general questions. We hope this information is useful to you.

 


FDA Plan for Statutory Compliance